Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You-Ping Liu

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 12, 2025
[Phase changes and quantity-quality transfer of raw material, calcined decoction pieces, and standard decoction of Ostreae Concha (Ostrea rivularis)]Hong-Yi Zhang, Jing-Wei Zhou, Jia-Wen Liu, et al.
Med (New York, N.Y.)|August 30, 2022
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinomaRui You, Xiong Zou, Xi Ding, et al.
The Laryngoscope|December 30, 2020
Transoral Robotic Retropharyngeal Lymph Node Dissection in Nasopharyngeal Carcinoma With Retropharyngeal Lymph Node RecurrenceXi Ding, Qing-Guang Lin, Xiong Zou, et al.
Head & Neck|September 28, 2020
Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrenceYou-Ping Liu, Shun-Lan Wang, Xiong Zou, et al.
International Journal of Cancer|May 3, 2019
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patientsRui You, You-Ping Liu, Mei Lin, et al.
Cancer Communications (London, England)|December 23, 2018
A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinomaXiong Zou, Shun-Lan Wang, You-Ping Liu, et al.
Eclinicalmedicine|July 7, 2023
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyXi Ding, Yi-Jun Hua, Xiong Zou, et al.
Cancer Communications (London, England)|November 16, 2019
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinomaYou-Ping Liu, Xing Lv, Xiong Zou, et al.
Oral Oncology|May 1, 2018
Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinomaMei Lin, Rui You, You-Ping Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2023
Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II StudyXi Ding, Wei-Jing Zhang, Rui You, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 12, 2025
[Phase changes and quantity-quality transfer of raw material, calcined decoction pieces, and standard decoction of Ostreae Concha (Ostrea rivularis)]Hong-Yi Zhang, Jing-Wei Zhou, Jia-Wen Liu, et al.
Med (New York, N.Y.)|August 30, 2022
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinomaRui You, Xiong Zou, Xi Ding, et al.
The Laryngoscope|December 30, 2020
Transoral Robotic Retropharyngeal Lymph Node Dissection in Nasopharyngeal Carcinoma With Retropharyngeal Lymph Node RecurrenceXi Ding, Qing-Guang Lin, Xiong Zou, et al.
Head & Neck|September 28, 2020
Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrenceYou-Ping Liu, Shun-Lan Wang, Xiong Zou, et al.
International Journal of Cancer|May 3, 2019
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patientsRui You, You-Ping Liu, Mei Lin, et al.
Cancer Communications (London, England)|December 23, 2018
A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinomaXiong Zou, Shun-Lan Wang, You-Ping Liu, et al.
Eclinicalmedicine|July 7, 2023
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyXi Ding, Yi-Jun Hua, Xiong Zou, et al.
Cancer Communications (London, England)|November 16, 2019
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinomaYou-Ping Liu, Xing Lv, Xiong Zou, et al.
Oral Oncology|May 1, 2018
Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinomaMei Lin, Rui You, You-Ping Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2023
Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II StudyXi Ding, Wei-Jing Zhang, Rui You, et al.
Pageof 9